Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Na Bangchang, Kesara ^a   Ruengweerayut, Ronnatrai ^b   Mahamad, Poonuch ^a   Ruengweerayut, Kulaya ^b   Chaijaroenkul, Wanna ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAE SOT GENERAL HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; DIHYDROARTEMISININ; MEFLOQUINE; PRIMAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MULTIDRUG RESISTANCE; MYANMAR; NONHUMAN; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; REINFECTION; THAILAND; TREATMENT RESPONSE; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; MIDDLE AGED; PLASMA; PLASMODIUM FALCIPARUM; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MASS SPECTROMETRY; MEFLOQUINE; MIDDLE AGED; MYANMAR; PLASMA; PLASMODIUM FALCIPARUM; THAILAND; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957557403     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-273     Document Type: Article

References (26)

1. Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand. K Na-Bangchang K Congpuong, Tohoku J Exp Med 2007 211 99 113 10.1620/tjem.211.99 17287593
2. WHO/HTM/MAL 2006.1108. World Health Organization Guidelines for the treatment of malaria, Geneva: The Organization 2006 http://www.who.int/malaria/ docs/TreatmentGuidelines2006.pdf
3. Status of malaria in Thailand. T Chareonviriyaphap MJ Bangs S Ratanatham, Southeast Asian J Trop Med Public Health 2000 31 225 237 11127318
4. Mefloquine-its 20 years in the Thai Malaria Control Program. C Wongsrichanalai S Prajakwong SR Meshnick GD Shanks K Thimasarn, Southeast Asian J Trop Med Public Health 2004 35 300 308 15691128
5. Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand. C Rojanawatsirivej S Vijaykadga I Amklad P Wilairatna S Looareesuwan, Southeast Asian J Trop Med Public Health 2003 34 536 541 15115123
6. Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border. C Rojanawatsirivet K Congpuong S Vijaykadga S Thongphua K Thongsri KN Bangchang P Wilairatana WH Wernsdorfer, Southeast Asian J Trop Med Public Health 2004 35 560 565 15689066
7. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. F Nosten C Luxemburger FO ter Kuile C Woodrow JP Eh T Chongsuphajaisiddhi NJ White, J Infect Dis 1994 170 971 977 7930743 (Pubitemid 24296580)
8. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. F Nosten M van Vugt R Price C Luxemburger KL Thway A Brockman R McGready F ter Kuile S Looareesuwan NJ White, Lancet 2000 356 297 302 10.1016/S0140-6736(00)02505-8 11071185
9. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. S Vijaykadga C Rojanawatsirivej S Cholpol D Phoungmanee A Nakavej C Wongsrichanalai, Trop Med Int Health 2006 11 211 219 10.1111/j.1365-3156.2005.01557.x 16451346
10. Evidence of artemisinin-resistant malaria in western Cambodia. H Noedl Y Se K Schaecher BL Smith D Socheat MM Fukuda, N Engl J Med 2008 359 2619 20 10.1056/NEJMc0805011 19064625
11. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. VI Carrara J Zwang EA Ashley RN Price K Stepniewska M Barends A Brockman T Anderson R McGready L Phaiphun S Proux M van Vugt R Hutagalung KM Lwin AP Phyo P Preechapornkul M Imwong S Pukrittayakamee P Singhasivanon NJ White F Nosten, PLoS One 2009 4 4551 10.1371/journal.pone.0004551 19234601
12. World Health Organization, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria (WHO/HTM/RBM/2003.50) WHO, Geneva 2003
13. Severe falciparum malaria. World Health Organization, Trans R Soc Trop Med Hyg 2000 94 1 90 10748883
14. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. A Cattamanchi D Kyabayinze A Hubbard PJ Rosenthal G Dorsey, Am J Trop Med Hyg 2003 68 133 139 12641400
15. Determination of mefloquine in biological fluids using high performance liquid chromatography. J Karbwang P Molunto K Na Bangchang D Bunnag, Southeast Asian J Trop Med Public Health 1989 20 55 60 2788925 (Pubitemid 19190847)
16. Development and validation of a liquid chromatography-mass spectrometry method for the simultaneous quantification of artesunate and dihydroartemisinin in human plasma. TD Thuy le N Hung le PT Danh K Na-Bangchang, Southeast Asian J Trop Med Public Health 2008 39 963 977 19062683
17. Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria. K Congpuong P Bualombai V Banmairuroi K Na-Bangchang, Malar J 2010 9 43 49 10.1186/1475-2875-9-43 20132537
18. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. M van Vugt A Brockman B Gemperli C Luxemburger I Gathmann C Royce T Slight S Looareesuwan NJ White F Nosten, Antimicrob Agents Chemother 1998 42 135 139 9449273 (Pubitemid 28053339)
19. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. RN Price F Nosten C Luxemburger M van Vugt L Phaipun T Chongsuphajaisiddhi NJ White, Trans R Soc Trop Med Hyg 1997 91 574 577 10.1016/S0035-9203(97)90032-8 9463672
20. The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia. Y Suputtamongkol S Chindarat S Silpasakorn S Chaikachonpatd K Lim K Chanthapakajee N Kaewkaukul V Thamlikitkul, Am J Trop Med Hyg 2003 68 620 623 12812357
21. Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam. K Na Bangchang J Karbwang V Banmairuroi D Bunnag T Harinasuta, Southeast Asian J Trop Med Public Health 1993 24 221 225 8266221
22. The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives. XD Luo CC Shen, Med Res Rev 1987 7 29 52 10.1002/med.2610070103 3550324
23. Comparative clinical trial of four regimens of dihydroartemisinin- mefloquine in multidrug-resistant falciparum malaria. K Na-Bangchang P Tippawangkosol R Ubalee S Chaovanakawee S Saenglertsilapachai K Karbwang, Trop Med Intern Hlth 1999 4 602 610 10.1046/j.1365-3156.1999.00458.x (Pubitemid 29470216)
24. Artemisinin-resistant malaria in Asia. H Noedl D Socheat W Satimai, N Engl J Med 2009 361 540 541 10.1056/NEJMc0900231 19641219
25. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. P Lim AP Alker N Khim NK Shah S Incardona S Doung P Yi DM Bouth C Bouchier OM Puijalon SR Meshnick C Wongsrichanalai T Fandeur J Le Bras P Ringwald F Ariey, Malar J 2009 8 11 20 10.1186/1475-2875-8-11 19138391
26. Geographic structuring of the Plasmodium falciparum sarco(endo)plasmic reticulum Ca2+ ATPase (PfSERCA) gene diversity. R Jambou A Martinelli J Pinto S Gribaldo E Legrand M Niang N Kim L Pharath B Volnay MT Ekala C Bouchier T Fandeur P Berzosa A Benito ID Ferreira C Ferreira PP Vieira MG Alecrim O Mercereau-Puijalon P Cravo, PLoS One 2010 5 9424 10.1371/journal.pone.0009424 20195531